antigen (bcma), cd3yrelapsed or refractory multiple myeloma tefibazumabaurexismabhumanizedclumping factor astaphylococcus aureus infection telimomab aritoxfabmouse telisotuzumabmabhumanizedhgfrcancer telisotuzumab vedotinmabhumanizedhgfrcancer tenatumomabmabmousetenascin ccancer teneliximabmabchimericcd40autoimmune diseases and prevention of organ transplant rejection teplizumabtzieldmabhumanizedcd3ydiabetes mellitus type 1 tepoditamabmabhumandendritic cell-associated lectin 2cancer teprotumumabtepezzamabhumanigf-1 receptor (cd221)ythyroid eye disease tesidolumabmabhumanc5 tetulomabmabhumanizedcd37cancer tezepelumabtezspiremabhumanthymic stromal lymphopoietin (tslp)yasthma tgn1412humanizedcd28chronic lymphocytic leukemia, rheumatoid arthritis tibulizumabmabhumanizedb-cell activating factor (baff)autoimmune disorders tildrakizumabilumyamabhumanizedil-23yimmunologically mediated inflammatory disorders tigatuzumabmabhumanizedtrail-r2cancer timigutuzumabmabhumanizedher2cancer timolumabmabhumanaoc3 tiragolumabmabhuman tiragotumabmabhumantigitcancer tislelizumabmabhumanizedpcdc1, cd279non-small cell lung cancer tisotumab vedotintivdakmabhumancoagulation factor iiiyrelapsed or refractory cervical cancer tixagevimabmabhumanspike protein receptor binding domain (rbd) of sars-cov-2emergency use authorization (eua) when used with cilgavimabcovid-19 tnx-650humanizedil-13hodgkin's lymphoma tocilizumabactemra, roactemramabhumanizedil-6 receptoryrheumatoid arthritis tomuzotuximabmabhumanizedepidermal growth factor receptor (egfr), her1cancer toralizumabmabhumanizedcd154 (cd40l)rheumatoid arthritis, lupus nephritis etc. tosatoxumabmabhumanstaphylococcus aureus tositumomabbexxarmousecd20yfollicular lymphoma tovetumabmabhumanpdgfracancer tralokinumabadtralza, adbrymabhumanil-13yatopic dermatitis trastuzumabherceptinmabhumanizedher2/neuybreast cancer trastuzumab duocarmazinekadcylamabhumanizedher2/neuybreast cancer trastuzumab emtansinekadcylamabhumanizedher2/neuybreast cancer trbs07ektomab3functgd2 gangliosidemelanoma tregalizumabmabhumanizedcd4 tremelimumabimjudomabhumanctla-4yhepatocellular carcinoma trevogrumabmabhumangrowth differentiation factor 8muscle atrophy due to orthopedic disuse and sarcopenia tucotuzumab celmoleukinmabhumanizedepcamcancer tuvirumabhumanhepatitis b viruschronic hepatitis b ublituximabbriumvimabchimericcd20ymultiple sclerosis, chronic lymphocytic leukemia ulocuplumabmabhumancxcr4 (cd184)hematologic malignancies urelumabmabhuman4-1bb (cd137)cancer etc. urtoxazumabmabhumanizedescherichia colidiarrhoea caused by e. coli ustekinumabstelaramabhumanil-12, il-23ymultiple sclerosis, psoriasis, psoriatic arthritis utomilumabmabhuman4-1bb (cd137)diffuse large b-cell lymphoma vadastuximab talirinemabchimericcd33acute myeloid leukemia vanalimabmabhumanizedcd40 vandortuzumab vedotinmabhumanizedsteap1cancer vantictumabmabhumanfrizzled receptorcancer vanucizumabmabhumanizedangiopoietin 2cancer vapaliximabmabchimericaoc3 (vap-1) varisacumabmabhumanvegf-aangiogenesis varlilumabmabhumancd27solid tumors and hematologic malignancies vatelizumabmabhumanizeditga2 (cd49b) vedolizumabentyviomabhumanizedintegrin α4 β7ycrohn's disease, ulcerative colitis veltuzumabmabhumanizedcd20non-hodgkin's lymphoma vepalimomabmabmouseaoc3 (vap-1)inflammation vesencumabmabhumannrp1solid malignancies vilobelimabgohibicmabchimericc5a receptor (c5a)emergency use authorization (eua)covid-19 visilizumabnuvionmabhumanizedcd3crohn's disease, ulcerative colitis vobarilizumabscfvhumanizedil-6 receptorinflammatory autoimmune diseases volociximabmabchimericintegrin α5β1solid tumors vonlerolizumabmabhumanizedcd134cancer vopratelimabmabhumanizedcd278, aka icos vorsetuzumab mafodotinmabhumanizedcd70cancer votumumabhumaspectmabhumantumor antigen ctaa16.88colorectal tumors vunakizumabmabhumanizedil-17a xentuzumabmabhumanizedigf-1, igf-2? xmab-5574humanizedcd19diffuse large b-cell lymphoma zalutumumabmabhumanepidermal growth factor receptor (egfr)squamous cell carcinoma of the head and neck zanolimumabmabhumancd4rheumatoid arthritis, psoriasis, t-cell lymphoma zatuximabmabchimericher1cancer zenocutuzumabmabhumanizederbb3 (her3)cancer ziralimumabmabhumancd147 (basigin) zolbetuximabmabchimericclaudin 18 isoform 2gastric cancer, gastrointestinal adenocarcinoma and pancreatic cancer zolimomab aritoxmabmousecd5systemic lupus erythematosus, graft-versus-host disease